NHS England has extended limits on prescribing intervals of several HRT products currently subject to a Serious Shortage Protocol (SSP).

The Serious shortage protocols (SSPs) limiting prescribing intervals of the named HRT products  to up to  three months have  been extended to October 28.

The only prescribing restrictions to be lifted from today relate to Premique low dose 0.3mg/1.5mg MR tablets.

Pharmacy representative PSNC has produced a table of the changes.